2000

December 20, 2000
Panacea Pharmaceuticals, Inc. President/CEO Presents Update on Alzheimer's Disease Drug Development Program During Interview on CEOcast.com

December 19, 2000
Panacea Pharmaceuticals, Inc. Announces New Publications Supporting Use of Cell Cycle Models for Alzheimer's Disease Drug Development

December 5, 2000
Panacea Pharmaceuticals, Inc. Announces Members of Scientific Advisory Board

November 14, 2000
Panacea Pharmaceuticals, Inc. Proceeds with Pre-Clinical Studies on Antisense Compound PAN-346 for Treating Brain Cancers

September 28, 2000
Panacea Pharmaceuticals, Inc. Announces Recent Publication Describing Its Technology for Treating Parkinson's Disease

September 27, 2000
Panacea Pharmaceuticals, Inc. Announces Completion of Series A Financing

September 6, 2000
Panacea Pharmaceuticals, Inc. Announces Appointment of New Board Member

August 29, 2000
Panacea Pharmaceuticals, Inc. President/CEO Interviewed on CEOcast.com

August 24, 2000
Panacea Pharmaceuticals, Inc. Appoints Carl R. Merril, M.D., as Chair of Scientific Advisory Board

August 3, 2000
Panacea Pharmaceuticals, Inc. Announces Closing of Initial Round of Financing

July 19, 2000
Panacea Pharmaceuticals, Inc. Announces Appointment of Several Key Management Positions to its Diagnostic Division

July 12, 2000
Panacea Pharmaceuticals, Inc. Announces Agreements Covering Drug Development Efforts Aimed at Cell Cycle Abnormalities in Alzheimer's Disease

July 10, 2000
Panacea Pharmaceuticals, Inc. Announces Agreements with Case Western Reserve University for Alzheimer's Disease Specific Oxidative Stress Model

July 7, 2000
Panacea Pharmaceuticals, Inc. Appoints Christopher Kircher, M.D. as Chair of Medical Advisory Board

June 27, 2000
Panacea Pharmaceuticals, Inc. Announces Appointment To Its Board Of Directors

June 21, 2000
Panacea Pharmaceuticals, Inc. Announces Agreements With Loyola Medical School For Parkinson's Disease Drug Development

June 13, 2000
Panacea Pharmaceuticals, Inc. Announces Appointment of Chief Financial Officer and Board Member

June 8, 2000
Panacea Pharmaceuticals, Inc. Appoints Vice President for Business Development and Director of Diagnostic Division

June 6, 2000
Panacea Pharmaceuticals, Inc. Announces the Licensing of Cancer Platform Technology and Signing of Collaborative Research Agreement with Rhode Island Hospital/Brown University